These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7426339)

  • 1. Murine melanoma: a model for intracranial metastasis.
    Raz A; Hart IR
    Br J Cancer; 1980 Aug; 42(2):331-41. PubMed ID: 7426339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines.
    Fidler IJ; Nicolson GL
    J Natl Cancer Inst; 1976 Nov; 57(5):1199-202. PubMed ID: 1003551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of mouse melanoma cell lines by their mortal malignancy using an experimental metastatic model.
    Nakamura K; Yoshikawa N; Yamaguchi Y; Kagota S; Shinozuka K; Kunitomo M
    Life Sci; 2002 Jan; 70(7):791-8. PubMed ID: 11833741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain meninges tumor formation by in vivo-selected metastatic B16 melanoma variants in mice.
    Kawaguchi T; Kawaguchi M; Miner KM; Lembo TM; Nicolson GL
    Clin Exp Metastasis; 1983; 1(3):247-59. PubMed ID: 6546202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic inefficiency in mice bearing B16 melanomas.
    Weiss L; Mayhew E; Rapp DG; Holmes JC
    Br J Cancer; 1982 Jan; 45(1):44-53. PubMed ID: 7059464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.
    Wang BS; McLoughlin GA; Richie JP; Mannick JA
    Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing CTL responses to melanoma cell vaccines in vivo: synergistic increases obtained using IFNgamma primed and IFNbeta treated B7-1+ B16-F10 melanoma cells.
    Dezfouli S; Hatzinisiriou I; Ralph SJ
    Immunol Cell Biol; 2003 Dec; 81(6):459-71. PubMed ID: 14636243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma.
    Hart IR; Fidler IJ
    Cancer Res; 1980 Jul; 40(7):2281-7. PubMed ID: 7388794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties.
    Irimura T; Gonzalez R; Nicolson GL
    Cancer Res; 1981 Sep; 41(9 Pt 1):3411-8. PubMed ID: 7260906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in cytotoxic effects of activated murine peritoneal macrophages and J774 monocytic cells on metastatic variants of B16 melanoma.
    Miner KM; Klostergaard J; Granger GA; Nicolson GL
    J Natl Cancer Inst; 1983 Apr; 70(4):717-24. PubMed ID: 6339778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor cell and host properties affecting the implantation and survival of blood-borne metastatic variants of B16 melanoma.
    Fidler IJ; Nicolson GL
    Isr J Med Sci; 1978 Jan; 14(1):38-50. PubMed ID: 632082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain surface invasion and metastasis of murine malignant melanoma variants.
    Nicolson GL; Kawaguchi T; Kawaguchi M; Van Pelt C
    J Neurooncol; 1987; 4(3):209-18. PubMed ID: 3559661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity.
    Fidler IJ; Gersten DM; Budmen MB
    Cancer Res; 1976 Sep; 36(9 pt.1):3160-5. PubMed ID: 975082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases.
    Poste G; Doll J; Brown AE; Tzeng J; Zeidman I
    Cancer Res; 1982 Jul; 42(7):2770-8. PubMed ID: 7083167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant potential of cells isolated from lymph node or brain metastases of melanoma patients and implications for prognosis.
    Zhang RD; Price JE; Schackert G; Itoh K; Fidler IJ
    Cancer Res; 1991 Apr; 51(8):2029-35. PubMed ID: 1826230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of B16 melanoma lung colony formation in C57BL/6 mice having marked granulocytosis.
    Ishikawa M; Koga Y; Hosokawa M; Kobayashi H
    Int J Cancer; 1986 Jun; 37(6):919-24. PubMed ID: 3710620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The selection and characterization of an invasive variant of the B16 melanoma.
    Hart IR
    Am J Pathol; 1979 Dec; 97(3):587-600. PubMed ID: 507192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple human chromosomes carrying tumor-suppressor functions for the mouse melanoma cell line B16-F10, identified by microcell-mediated chromosome transfer.
    Kugoh H; Nakamoto H; Inoue J; Funaki K; Barrett JC; Oshimura M
    Mol Carcinog; 2002 Nov; 35(3):148-56. PubMed ID: 12410566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model of human cancer metastasis: extensive spontaneous and artificial metastasis of a human pigmented melanoma and derived variant sublines in nude mice.
    Kerbel RS; Man MS; Dexter D
    J Natl Cancer Inst; 1984 Jan; 72(1):93-108. PubMed ID: 6582307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular behavior of metastatic B16 melanoma in experimental blood-borne implantation and cerebral invasion. An electron microscopic study.
    Kawaguchi T; Kawaguchi M; Dulski KM; Nicolson GL
    Invasion Metastasis; 1985; 5(1):16-30. PubMed ID: 3980160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.